(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and Friday and not separately reported by Alliance News: Read More
(Alliance News) - SkinBioTherapeutics PLC on Monday said losses in financial 2025 were larger than initially reported after an investigation found its previous chief executive had "fabricated" figures. Read More
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Friday and not separately reported by Alliance News: Read More
(Alliance News) - SkinBioTherapeutics PLC shares slid on Friday after the firm said it will be suspended from trading on the AIM market at the start of April until the review of its former chief executive's conduct concludes. Read More
(Alliance News) - SkinBioTherapeutics on Monday confirmed the appointment of Interim Chief Executive Officer Rachel Parsonage to its board after completing regulatory due diligence. Read More
(Alliance News) - SkinBioTherapeutics PLC on Monday announced Rachel Parsonage has been appointed as interim chief executive officer effective immediately as the life science firm tries to carve out a way forward from the suspension and resignation of its past CEO. Read More
(Alliance News) - Stock prices in London closed higher on Friday, as a swathe of domestic economic data was well-received and the US Supreme Court ruled President Donald Trump's tariff programme is illegal. Read More
SkinBioTherapeutics PLC - Newcastle Upon Tyne, England-based life sciences - Non-Executive Director Alyson Levett will oversee an independent investigation of the events that led to the departure of Stuart Ashman as chief executive officer. Levett, who chairs the board's audit committee, will work with FRP Advisory, which the board has engaged to undertake a "forensic review". Read More
(Alliance News) - London stocks opened higher on Friday, following news from the UK of an expected public sector surplus and faster-than-expected growth in retail sales for January. Read More
(Alliance News) - ProBiotix Health PLC on Monday said it believes a fall in its share price may result from "mistaken assumptions" about events at SkinBioTherapeutics PLC. Read More
(Alliance News) - Shares in SkinBioTherapeutics PLC plunged on Monday after the company said its probe into the conduct of its former boss will result in a reduction of revenue and profit. Read More
(Alliance News) - The FTSE 100 was called higher on Monday, as Beazley extends its deadline for Zurich Insurance to make an acquisition offer. Read More